Latest Capital Markets News

Augustus Minerals is progressing its second-in-time licence application for the Mt Kare Gold Project in Papua New Guinea, aiming to unlock a high-grade alkali epithermal deposit near the Porgera mine. The company is preparing for rapid underground development and aggressive drilling, contingent on regulatory outcomes.

Locksley Resources has listed on the Frankfurt Stock Exchange, boosting its profile in Europe while advancing its Mojave critical minerals project in the U.S. The company is also exploring multiple pathways to enter U.S. capital markets and has secured key government registrations.

Xstate Resources has secured $2.14 million through its Re-compliance Prospectus offer and is on track to meet ASX conditions for re-listing, with drilling at its Diona Project set to begin in late September.

EQ Resources has successfully raised $22.5 million through an institutional placement, aiming to accelerate production and strengthen its financial position at the Mt Carbine tungsten project.

Dotz Nano has responded to an ASX price query following unusual trading activity, confirming no undisclosed information and reaffirming compliance with continuous disclosure rules.

Beacon Minerals has sold a significant portion of its Astral Resources shares, raising $5.9 million to support development at its Jaurdi Mill and Iguana projects.

Warriedar Resources has secured a crucial ASX waiver allowing the cancellation of 5 million unlisted options without shareholder approval, smoothing the path for Capricorn Metals’ acquisition scheme.

Buru Energy has successfully raised $2.1 million through a share placement and launched a $3 million Share Purchase Plan to advance its Rafael Gas Project, targeting a Final Investment Decision by late 2026 and first cash flow by early 2028.

Sayona Mining has completed its merger with Piedmont Lithium, creating a new lithium entity with equal ownership and a refreshed board. The combined company, soon to be renamed Elevra Lithium, aims to strengthen its position in the global energy transition.

RooLife Group Ltd reported a sharp 51% revenue decline to $4.62 million and a 31% increase in net loss to $2.76 million for FY2025, as it pivots towards higher-margin sectors including renewable energy and global social commerce.

Nanoveu Limited’s transformative half-year report highlights its EMASS acquisition, executive hires, and technology advances amid a $3 million loss and new US OTCQB listing.

Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.